In situ crosslinkable heparin-containing poly(ethylene glycol) hydrogels for sustained anticoagulant release (Q33894433)

29 July 2017

In situ crosslinkable heparin-containing poly(ethylene glycol) hydrogels for sustained anticoagulant release (English)

1 reference

29 July 2017

1 reference

1 reference

1 reference

5

Kristi L Kiick

1 reference

29 July 2017

Aaron D Baldwin

1

1 reference

29 July 2017

Karyn G Robinson

2

1 reference

29 July 2017

Jaimee L Militar

3

1 reference

29 July 2017

Christopher D Derby

4

1 reference

29 July 2017

Robert E Akins

6

1 reference

29 July 2017

21 May 2012

1 reference

Journal of Biomedical Materials Research Part A

29 July 2017

1 reference

29 July 2017

100

1 reference

29 July 2017

8

1 reference

29 July 2017

2106-2118

1 reference

Treatment of Deep Vein Thrombosis with Continuous IV Infusion of LMWH: A Retrospective Study in 32 Children

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Low-molecular-weight heparin overdose: management by observation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Toward effective long-term prevention of thromboembolism: novel oral anticoagulant delivery systems

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Anticoagulant efficacy of solid oral formulations containing a new heparin derivative

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Polysaccharide-modified synthetic polymeric biomaterials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor xa inhibitors in development

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Injectable hydrogels as unique biomedical materials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Differentiating low-molecular-weight heparins based on chemical, biological, and pharmacologic properties: implications for the development of generic versions of low-molecular-weight heparins

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Triggers, targets and treatments for thrombosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Pharmacokinetics and pharmacodynamics of oral heparin solid dosage form in healthy human subjects

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Evaluation of the Oral Bioavailability of Low Molecular Weight Heparin Formulated With Glycyrrhetinic Acid as Permeation Enhancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Production of heparin-functionalized hydrogels for the development of responsive and controlled growth factor delivery systems

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Beyond heparin and warfarin: the new generation of anticoagulants

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Effects of neighboring sulfides and pH on ester hydrolysis in thiol-acrylate photopolymers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Projections of global mortality and burden of disease from 2002 to 2030

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

A colorimetric method for the standardization of heparin preparations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Oral heparin: status review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

PEGylation, successful approach to drug delivery

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Direct thrombin inhibitors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Preparation of cross-linked hyaluronic acid film using 2-chloro-1-methylpyridinium iodide or water-soluble 1-ethyl-(3,3-dimethylaminopropyl)carbodiimide

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

In situ crosslinkable hyaluronan hydrogels for tissue engineering

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Hydrogels for biomedical applications

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

The heparin-protamine interaction. A review.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Erosion kinetics of hydrolytically degradable polymers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Changes in plasma warfarin levels and variations in steady-state prothrombin times

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Development of the human coagulation system in the full-term infant

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Direct thrombin inhibitors

5 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34050

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34050

Acylated non-alpha-amino acids as novel agents for the oral delivery of heparin sodium, USP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34050

In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34050

Oral bioavailability of a low molecular weight heparin using a polymeric delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34050

Polycationic lipophilic-core dendrons as penetration enhancers for the oral administration of low molecular weight heparin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34050

Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34050

Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34050

Protein-heparin interactions measured by BIAcore 2000 are affected by the method of heparin immobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34050

Subcutaneous tissue mechanical behavior is linear and viscoelastic under uniaxial tension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34050

Controlling network structure in degradable thiol-acrylate biomaterials to tune mass loss behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34050

The effect of the linker on the hydrolysis rate of drug-linked ester bonds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34050

Structural features of low-molecular-weight heparins affecting their affinity to antithrombin.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096162

Heparin neutralization by recombinant platelet factor 4 and protamine

29 October 2018

1 reference

12 December 2020

Maturation of the hemostatic system during childhood

1 reference

12 December 2020

Differential reactivity of maleimide and bromoacetyl functions with thiols: application to the preparation of liposomal diepitope constructs

1 reference

12 December 2020

Treatment of deep vein thrombosis with continuous intravenous infusion of LMWH in children--an alternative to subcutaneous application when needed

1 reference

12 December 2020

PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor

1 reference

12 December 2020

Synthesis and physicochemical characterization of end-linked poly(ethylene glycol)-co-peptide hydrogels formed by Michael-type addition

1 reference

12 December 2020

New heparin complexes active by intestinal absorption: I-multiple ion pairs with basic organic compounds

1 reference

12 December 2020

Oral delivery of heparin in combination with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate: pharmacological considerations

1 reference

12 December 2020

Development of chitosan/polyethylene vinyl acetate co-matrix: controlled release of aspirin-heparin for preventing cardiovascular thrombosis

1 reference

12 December 2020

Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humans

1 reference

12 December 2020

Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis

1 reference

12 December 2020

Polymeric systems for controlled drug release

1 reference

12 December 2020

Identifiers

DOI

10.1002/JBM.A.34050

1 reference

29 July 2017

1 reference

29 July 2017

1 reference